3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Endocrine
1
Conditions
Neoplasms
2
Brain Neoplasms
2
Sarcoma
1
Pituitary Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Hodgkin Disease
1
Glioma
1
Fatigue
1
Cytokine Release Syndrome
1
Astrocytoma
1
Interventions
Radiosurgery
28
Magnetic Resonance Spectroscopy
27
Dexmedetomidine
8
Radiotherapy
7
Radiation
7
Proton Therapy
7
Mental Status and Dementia Tests
7
Magnetic Resonance Imaging
7
Exercise
6
Surgical Procedures, Operative
5
Specimen Handling
5
Saline Solution
5
Blood Specimen Collection
5
Bevacizumab
5
Remifentanil
4
Radiotherapy, Intensity-Modulated
4
Propofol
4
alovudine
3
Transcranial Magnetic Stimulation
3
Temozolomide
3
Resistance Training
3
Methods
3
Mannitol
3
Diffusion Tensor Imaging
3
Cognitive Training
3
gadobutrol
2
gadobenic acid
2
Yoga
2
Vitamin D
2
Ultrasonography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Brain Neoplasms
×
Neuropsychological Tests
×
Clear all
NCT05340881
2025-09-18
SLEPBT
Baylor College of Medicine
Phase NA
Recruiting
40 enrolled
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled